“It may be that, some ages hence... the restoration of grey hairs to juvenility and the renewing of the exhausted marrow may at length be elicited without a miracle”
Joseph Glanvill,
1661AD
People
Executive Chairman: Richard Archer
Richard was founder of The Automation Partnership Group plc ("TAP") and was its CEO until he retired in 2004. TAP is a self-financed, privately-owned UK company and a major global player in the automation of complex cell culture processes and ultra high throughput screening. Richard is an engineer by background but has spent the last twenty years working with life science based industries and has a wide network of senior contacts in the pharmaceutical and biotechnology sectors. Richard is also a director of SciBridge and a number of other university spin out companies - Gentronix, MagneCell, and Akubio. He is also a Senior Industrial Fellow at The University of Cambridge, Chairman of an EPSRC funded national research programme of manufacturing research in Regenerative Medicine and also represents healthcare manufacturing issues on government strategic bodies."
Executive Director & Founder: Professor Peter Andrews
Professor Peter Andrews studied a cancer-derived equivalent of embryonic stem (ES) cells, embryonal carcinoma (EC) cells for more than 20 years, first in the Wistar Institute in Philadelphia and more recently in Sheffield. Read more...
Executive Director & Founder: Professor Harry Moore
Professor Harry Moore has worked for many years on human fertility and early embryogenesis, and was one of the first to obtain a Human Fertilization and Embryo Authority (HFEA) licence for the derivation of HESC lines. Read more...
Non Executive Director: Dr Simon Fishel
Since August 1997 Dr Simon Fishel BSc PhD has been a Director of Centres for Assisted Reproduction (CARE) Ltd. Dr Fishel, Mr Ken Dowell and Mr Simon Thornton formed CARE in 1997 in partnership with the General Healthcare Group. Dr Fishel gained his PhD at the University of Cambridge under the supervision of Professor Robert Edwards. In 1978 he became a Cambridge University Lecturer and subsequently, while maintaining his University position, became Deputy Scientific Director at the world's first "test tube baby clinic" at Bourn Hall in Cambridge with Robert Edwards and Patrick Steptoe.
Non Executive Director: Dr Peter Grant
Dr Peter Grant represents Biofusion plc. Peter was part of the start-up team at Enzymatix Limited ("Enzymatix"). During the next five years Enzymatix grew five independent research areas with Peter as the Head of Research and Development. Two of these areas were later spun-out to form Chiros Limited (later Chiroscience, now merged with Celltech plc) and Celsis, with Peter as a co-founder and Research and Development Director. Following venture capital funding rounds, he was an integral part of the team that successfully floated Celsis on the full list of the London Stock Exchange in July 1993. He is an Executive Director of Biofusion plc and non-executive director of Adjuvantix Limited, Asterion Limited, Diurnal Limited, CellTran Limited and part-time CEO of Asterion Limited.